BRIDGEWAY CAPITAL MANAGEMENT, LLC - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 91 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$184,000
-44.4%
55,686
-40.3%
0.00%
-50.0%
Q1 2016$331,00093,2000.01%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
JW Asset Management, LLC 289,664$434,0000.43%
SALZHAUER MICHAEL 220,153$330,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,644,583$2,467,0000.08%
Brown Advisory Securities, LLC 272,000$408,0000.08%
Par Capital Management 4,431,301$6,647,0000.07%
ISTHMUS PARTNERS, LLC 176,170$264,0000.07%
FRANKLIN STREET ADVISORS INC /NC 96,429$145,0000.02%
GSA CAPITAL PARTNERS LLP 262,544$394,0000.02%
Ballentine Partners, LLC 100,000$150,0000.01%
NWAM LLC 20,000$30,0000.01%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders